SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001730463-19-000011
Filing Date
2019-08-08
Accepted
2019-08-08 16:36:26
Documents
77
Period of Report
2019-06-30

Document Format Files

Seq Description Document Type Size
1 6-K autolus-20190630x6k.htm 6-K 27637
2 EXHIBIT 99.1 exhibit991-consolidatedfin.htm EX-99.1 697631
3 EXHIBIT 99.2 exhibit992-operatingresult.htm EX-99.2 237468
  Complete submission text file 0001730463-19-000011.txt   4832910

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE DOCUMENT autl-20190630.xml EX-101.INS 799761
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT autl-20190630.xsd EX-101.SCH 44800
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT autl-20190630_cal.xml EX-101.CAL 74071
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT autl-20190630_def.xml EX-101.DEF 197284
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT autl-20190630_lab.xml EX-101.LAB 535323
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT autl-20190630_pre.xml EX-101.PRE 344857
Mailing Address FOREST HOUSE, 58 WOOD LANE WHITE CITY LONDON X0 W12 7RZ
Business Address FOREST HOUSE, 58 WOOD LANE WHITE CITY LONDON X0 W12 7RZ 44 20 3829 6230
Autolus Therapeutics plc (Filer) CIK: 0001730463 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-38547 | Film No.: 191010097
SIC: 2836 Biological Products, (No Diagnostic Substances)